Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002529816 | SCV000754757 | pathogenic | Citrullinemia | 2024-01-25 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 335 of the ASS1 protein (p.Arg335Cys). This variant is present in population databases (rs373514077, gnomAD 0.08%). This missense change has been observed in individual(s) with citrullinemia (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 528370). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ASS1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000633519 | SCV002789973 | uncertain significance | Citrullinemia type I | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000633519 | SCV003825142 | uncertain significance | Citrullinemia type I | 2021-12-28 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000633519 | SCV004202449 | likely pathogenic | Citrullinemia type I | 2024-03-29 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000633519 | SCV001457310 | uncertain significance | Citrullinemia type I | 2020-04-13 | no assertion criteria provided | clinical testing |